Voyager Therapeutics Inc (VYGR)

Schlusskurs vom Vortag:

$8.57

Offen:

$8.65

24-Stunden-Volumen:

651.61K

Marktkapitalisierung:

$469.37M

Einnahmen:

$250.01M

Nettoeinkommen (Verlust:

$132.33M

KGV:

3.8018

EPS:

2.27

Netto-Cashflow:

$74.66M

1W Leistung:

+2.25%

1M Leistung:

+8.15%

6M Leistung:

+31.76%

1J Leistung:

-24.07%

1-Tages-Spanne:

$8.30

$8.77

52-Wochen-Spanne:

$6.06

$14.34

Voyager Therapeutics Inc Stock (VYGR) Company Profile

Firmenname

Voyager Therapeutics Inc

Sektor

Healthcare (1211)

Branche

Biotechnology (697)

Telefon

857-259-5340

Adresse

75 Sidney Street, Cambridge, MA

Mitarbeiter

88

Twitter

@VoyagerTx

Nächster Verdiensttermin

2024-06-05

Neueste SEC-Einreichungen

VYGR's Discussions on Twitter

Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-05-10	Eingeleitet	Truist	Buy
2023-03-10	Eingeleitet	Oppenheimer	Outperform
2021-10-07	Hochstufung	Robert W. Baird	Neutral → Outperform
2021-02-26	Herabstufung	Robert W. Baird	Outperform → Neutral
2021-02-03	Herabstufung	BTIG Research	Buy → Neutral
2021-02-03	Herabstufung	Wedbush	Outperform → Neutral
2020-12-24	Herabstufung	Cantor Fitzgerald	Overweight → Neutral
2020-12-23	Herabstufung	Raymond James	Outperform → Mkt Perform
2020-11-11	Herabstufung	Oppenheimer	Outperform → Perform
2020-11-10	Herabstufung	Raymond James	Strong Buy → Outperform
2020-11-10	Herabstufung	Wells Fargo	Overweight → Equal Weight
2020-03-19	Eingeleitet	The Benchmark Company	Buy
2020-02-06	Eingeleitet	Oppenheimer	Outperform
2018-11-15	Hochstufung	Raymond James	Outperform → Strong Buy
2018-09-10	Fortgesetzt	BTIG Research	Buy
2018-09-10	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2018-06-04	Eingeleitet	H.C. Wainwright	Buy
2018-03-12	Herabstufung	Evercore ISI	Outperform → In-line
2018-03-12	Herabstufung	Wedbush	Outperform → Neutral
2018-02-02	Eingeleitet	Morgan Stanley	Overweight
2017-11-28	Fortgesetzt	Piper Jaffray	Overweight
2017-10-31	Eingeleitet	Robert W. Baird	Outperform
2017-10-27	Eingeleitet	Canaccord Genuity	Buy
2017-10-23	Bestätigt	Stifel	Buy
2017-10-12	Eingeleitet	Raymond James	Outperform
2017-08-17	Eingeleitet	Evercore ISI	Outperform
2017-07-28	Fortgesetzt	Stifel	Buy

Alle ansehen

Voyager Therapeutics Inc Aktie (VYGR) Neueste Nachrichten

Voyager Therapeutics (NASDAQ:VYGR) Rating Reiterated by HC Wainwright - MarketBeat

MarketBeat

Q2 2024 EPS Estimates for Voyager Therapeutics, Inc. Boosted by Analyst (NASDAQ:VYGR) - MarketBeat

MarketBeat

Wedbush Weighs in on Voyager Therapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:VYGR) - Defense World

Defense World

Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the ... - GlobeNewswire

GlobeNewswire

Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer’s Disease

GlobeNewswire Inc.

Voyager's journey to identify a new shuttle mechanism to bring gene therapies into the brain - BioCentury

BioCentury

Finanzdaten der Voyager Therapeutics Inc-Aktie (VYGR)

Voyager Therapeutics Inc (VYGR) Umsatz 2024

Voyager Therapeutics Inc (VYGR) Nettogewinn 2024

Voyager Therapeutics Inc (VYGR) Free Cashflow 2024

Voyager Therapeutics Inc (VYGR) Gewinn je Aktie 2024